GHR and cancer: Recently, subjects with deficiencies in growth hormone receptor and insulin-like growth factor have shown a reduced cancer mortality highlighting a role of pro-growth pathways, oxidative stress, and age-dependent genomic instability in human oncogenesis (7) in a study of cancer incidence in more than 16,000 patients with sickle cells anemia (SCA), melanoma was not listed (8).